Literature DB >> 23587907

A pragmatic and evidence-based management of ectopic pregnancy.

Galia Oron1, Togas Tulandi.   

Abstract

The incidence of ectopic pregnancy is approximately 2% of all pregnancies, and it remains the leading cause of death in early pregnancy. Over 95% of ectopic pregnancies are tubal pregnancies, and the remainders are nontubal pregnancies. The highest risk factor for ectopic pregnancy is a previous tubal pregnancy followed by previous tubal surgery, tubal sterilization, tubal pathology, and current intrauterine device use. The apparent increase in the incidence of nontubal ectopic pregnancy including heterotopic pregnancy may be attributed to the increasing number of pregnancies because of in vitro fertilization treatment. In most cases, an ectopic pregnancy can be treated medically with a single dose of methotrexate. Surgical treatment is still needed in women who are hemodynamically unstable and in those who do not fulfill the criteria for methotrexate treatment. Usually surgical treatment can be performed by laparoscopy and in some cases by hysteroscopy. Laparotomy is rarely needed even in women with intraperitoneal bleeding.
Copyright © 2013 AAGL. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cervical pregnancy; Cesarean scar pregnancy; Ectopic pregnancy; Interstitial pregnancy; Laparoscopy; Methotrexate

Mesh:

Year:  2013        PMID: 23587907     DOI: 10.1016/j.jmig.2013.02.004

Source DB:  PubMed          Journal:  J Minim Invasive Gynecol        ISSN: 1553-4650            Impact factor:   4.137


  11 in total

Review 1.  Diagnostic Methods of Ectopic Pregnancy and Early Pregnancy Loss: a Review of the Literature.

Authors:  A Hamza; G Meyberg-Solomayer; I Juhasz-Böss; R Joukhadar; Z Takacs; E-F Solomayer; S Baum; J Radosa; L Mavrova; D Herr
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-04       Impact factor: 2.915

Review 2.  Ectopic pregnancy secondary to in vitro fertilisation-embryo transfer: pathogenic mechanisms and management strategies.

Authors:  Bassem Refaat; Elizabeth Dalton; William L Ledger
Journal:  Reprod Biol Endocrinol       Date:  2015-04-12       Impact factor: 5.211

3.  A rare case of bilateral ectopic pregnancy and differential diagnosis of gestational trophoblastic disease.

Authors:  Maliheh Arab; Seyyedeh Neda Kazemi; Zahra Vahedpoorfard; Adeleh Ashoori
Journal:  J Reprod Infertil       Date:  2015 Jan-Mar

4.  Pretreatment serum human chorionic gonadotropin cutoff value for medical treatment success with single-dose and multi-dose regimen of methotrexate in tubal ectopic pregnancy.

Authors:  Junhwan Kim; Young Mi Jung; Da Yong Lee; Byung Chul Jee
Journal:  Obstet Gynecol Sci       Date:  2017-01-19

Review 5.  MicroRNAs as Potential Serum Biomarkers for Early Detection of Ectopic Pregnancy.

Authors:  Emmanuel N Kontomanolis; Sofia Kalagasidou; Zacharias Fasoulakis
Journal:  Cureus       Date:  2018-03-19

6.  Use of methotrexate in the treatment of ectopic pregnancies: a retrospective single center study.

Authors:  C Beguin; G Brichant; L De Landsheere; L Tebache; S Karampelas; L Seidel; M Nisolle
Journal:  Facts Views Vis Obgyn       Date:  2020-03-27

Review 7.  Spontaneous Heterotopic Pregnancy: Case Report and Literature Review.

Authors:  Miglė Černiauskaitė; Brigita Vaigauskaitė; Diana Ramašauskaitė; Mindaugas Šilkūnas
Journal:  Medicina (Kaunas)       Date:  2020-07-22       Impact factor: 2.430

8.  Which Protocol is better for Treatment of Ectopic Pregnancy by Methotrexate? Single-dose or Multiple-dose.

Authors:  Behnaz Khani; Fariba Behnamfar; Leila Taghiyar
Journal:  Adv Biomed Res       Date:  2020-10-30

9.  Predictive factors of methotrexate treatment success in ectopic pregnancy: A single-center tertiary study.

Authors:  Cigdem Pulatoglu; Ozan Dogan; Alper Basbug; Aski Ellibes Kaya; Ahmet Yildiz; Osman Temizkan
Journal:  North Clin Istanb       Date:  2018-09

10.  Ectopic Cervical Pregnancy: Treatment Route.

Authors:  Guglielmo Stabile; Francesco Paolo Mangino; Federico Romano; Giulia Zinicola; Giuseppe Ricci
Journal:  Medicina (Kaunas)       Date:  2020-06-12       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.